Fonte: Cardiovascular Research. Unidades: ICB, FMRP
Assunto: FARMACOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Victor Vitorino et al. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. Cardiovascular Research, v. 89, n. 3, p. 614-622, 2011Tradução . . Disponível em: https://doi.org/10.1093/cvr/cvq338. Acesso em: 19 abr. 2024.APA
Lima, V. V., Giachini, F. R. C., Carneiro, F. S., Carvalho, M. H. C. de, Fortes, Z. B., Webb, R. C., & Tostes, R. C. (2011). O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway. Cardiovascular Research, 89( 3), 614-622. doi:10.1093/cvr/cvq338NLM
Lima VV, Giachini FRC, Carneiro FS, Carvalho MHC de, Fortes ZB, Webb RC, Tostes RC. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway [Internet]. Cardiovascular Research. 2011 ; 89( 3): 614-622.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1093/cvr/cvq338Vancouver
Lima VV, Giachini FRC, Carneiro FS, Carvalho MHC de, Fortes ZB, Webb RC, Tostes RC. O-GlcNAcylation contributes to the vascular effects of ET-1 via activation of the RhoA/Rho-kinase pathway [Internet]. Cardiovascular Research. 2011 ; 89( 3): 614-622.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1093/cvr/cvq338
